SCHEMBL4540065

SCHEMBL4540065

Cn1ncc(Cl)c1-c1csc(C(=O)NC(Cc2ccccc2)C(NC(=O)O)C(C)(C)C)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 7/20 0.45
AKT2 P31751 3/20 0.41
AKT3 Q9Y243 3/20 0.41
ROCK2 O75116 2/20 0.41
PRKCB P05771 2/20 0.41
PRKCA P17252 2/20 0.41
PRKACA P17612 2/20 0.41
PRKACB P22694 2/20 0.41
ROCK1 Q13464 2/20 0.41
PKN1 Q16512 2/20 0.41
PRKD2 Q9BZL6 2/20 0.41
CIT O14578 1/20 0.41
HTR2A P28223 1/20 0.38
MAPK1 P28482 5/20 0.38
ITGA4 P13612 6/20 0.37
ITGB7 P26010 6/20 0.37
ITGB1 P05556 5/20 0.37
SGK1 O00141 1/20 0.35
PRKD3 O94806 1/20 0.35
LATS1 O95835 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4541583 0.91 ITGB1 (0.38) AKT1AKT2AKT3ROCK2PRKCB
SCHEMBL4375486 0.83 MAPK1 (0.36) AKT1MAPK1
SCHEMBL1529417 0.83 AKT1 (0.59) AKT1AKT2AKT3ROCK2PRKCB
SCHEMBL1529885 0.80 AKT1 (0.46) AKT1AKT2AKT3ROCK2PRKCB
SCHEMBL4552985 0.79 AKT1 (0.43) AKT1AKT2AKT3ROCK2PRKCB
SCHEMBL4378235 0.79 MMP12 (0.40) AKT1MAPK1
SCHEMBL12679242 0.78 AKT1 (0.45) AKT1AKT2AKT3ROCK2PRKCB
SCHEMBL4374524 0.78 ALDH1A1 (0.47)
SCHEMBL4583485 0.78 ALDH1A1 (0.47)
SCHEMBL4544057 0.76 ULK1 (0.39) AKT1MAPK1ITGA4ITGB7ITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2117523-A1 INHIBITORS OF AKT ACTIVITY SmithKline Beecham Corporation (US) 2009-11-18 EP disclosed
WO-2008098104-A1 INHIBITORS OF AKT ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2008-08-14 WO disclosed